Deciphera Shareholders to Receive $25.60 per Share in Cash Decipheraโs Kinase Inhibitor Expertise and Established Commercialization Platform in...
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new...
โ Fourth Quarter 2023 Total Revenue of $48.3 Million and Full Year 2023 Revenue of $163.4 Million; QINLOCKยฎ Net Product Revenue Increased 27% to...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.